Feed aggregator
Survey reveals why some people turn to unregulated cannabis to treat medical conditions
Use of medical cannabis has been on the rise since it first became available to Utah patients in 2020. A medical cannabis card, which can be prescribed for difficult-to-treat conditions including PTSD and chronic pain, allows a patient to access licensed cannabis products in designated pharmacies.
Closed Loop Medicine launches first personalized GLP-1 dosing platform In U.S.
Closed Loop Medicine Ltd (CLM), a leader in personalized pharmaceutical dosing, today announced the U.S. launch of WeDosify, which enables clinicians to personalize GLP-1 titration at scale.
AI tool analyzes brain activity to support and prioritize autism assessments
Scientists have developed and tested a deep-learning model that could support clinicians by providing accurate results and clear, explainable insights – including a model-estimated probability score for autism.
New findings support low-dose ATG to delay progression of type 1 diabetes
New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published simultaneously in The Lancet shows that a much lower dose than previously thought of the old immunomodulatory drug anti-thymocyte globulin (ATG) is safe and effective in preventing progression of type 1 diabetes (T1D) in young people.
Study uncovers new strategy to boost life-saving cervical cancer screenings
Cervical cancer is the fourth most common cancer among women globally, according to the World Health Organization. It accounted for 660,000 new cases and 350,000 deaths in 2022.
Genomic testing speeds patient accrual in high-risk prostate cancer trial
The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed accrual and met its accrual milestone of 2,478 patients approximately two years earlier than the trial's anticipated accrual completion date.
Hyperemesis gravidarum associated with increased neuropsychiatric disorders in pregnancy
The largest study on pregnant women with excessive nausea and vomiting (hyperemesis gravidarum) has identified increased risks of numerous neuropsychiatric and mental health outcomes.
Study identifies immune biomarkers for personalized therapies in pediatric germ cell tumors
A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible biomarkers that could guide the development of more personalized therapies for pediatric germ cell tumors (GCTs).
Study reveals how a little-understood protein contributes to blood vessel leakage
A new study from the University of Oklahoma reveals how a little-understood protein, CD82, contributes to blood vessel leakage, a process that initiates inflammation but becomes dangerous when it occurs during severe inflammatory diseases such as sepsis, acute respiratory distress syndrome and COVID-19.
Genomic studies reveal human influence on mosquito evolution and disease spread
Two of the world's deadliest mosquito vectors – Aedes aegypti and Anopheles funestus – have evolved, spread, and adapted in ways that complicate global disease control, two studies show.
Study reveals early nicotinamide use reduces risk of aggressive skin cancers
A large U.S. Department of Veterans Affairs cohort study found that Nicotinamide use was associated with a 14% lower risk of new keratinocyte skin cancers, driven by a 22% reduction in cSCC and no reduction in BCC. The strongest benefit (56% lower risk) appeared when nicotinamide was started after a patient’s first skin cancer, with diminishing returns after multiple cancers.
Climate change is already driving heat mortality and massive economic losses
Researchers systematically identified just 20 studies directly linking human-driven climate change to specific health impacts and deaths worldwide. They estimate tens of billions in annual economic losses and warn of inequities in research leadership and data coverage.
AI model maps lifetime disease risks to transform future healthcare planning
Researchers developed Delphi-2M, a transformer-based AI trained on UK Biobank and Danish health data to predict and simulate lifetime trajectories for 1,256 diseases. It accurately forecasted long-term multimorbidity risks, generated synthetic health records, and highlighted comorbidity patterns while exposing key biases.
PANoptosis emerges as a promising strategy against liver cancer
Liver cancer, particularly hepatocellular carcinoma (HCC), remains one of the deadliest cancers, driven by high recurrence and resistance to therapy.
Microplastics pose potential risks to bone health
The production and use of over 400 million tons of plastic each year has polluted beaches, rivers, and even the deepest parts of the ocean, reaching depths of up to 11,000 meters.
Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial
In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with obesity but no diabetes. It also improved multiple cardiometabolic markers with a safety profile similar to other GLP-1 receptor agonists.
Digital twin of lung cancer cell offers new insights into tumor growth and treatment
An enhanced computer model is now helping to provide fresh insights into cancer-cell growth and how it can be stopped. The digital cell model represents another step towards individualized cancer treatment.
Evening meals hold the key to morning glucose control in prediabetes
The way glucose is regulated at night plays a key role in fasting glucose levels the next morning, when blood sugar is expected to be at its lowest.
New class of antibiotics shows potent activity against multidrug-resistant bacteria
Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity against some of the world's most dangerous multidrug-resistant (MDR) bacteria.
Real-time blood testing shows promise for preventing maternal deaths from hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, is a leading cause of maternal mortality around the world.




